Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Elvucitabine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Elvucitabine?

Elvucitabine is an investigational drug.

There have been 6 clinical trials for Elvucitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2006.

The most common disease conditions in clinical trials are HIV Infections, Immunologic Deficiency Syndromes, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are Achillion Pharmaceuticals, Bellos, Nicholaos C., M.D., and Thomas Jefferson University.

Recent Clinical Trials for Elvucitabine
An Open Label Treatment Protocol to Provide Continued Elvucitabine TreatmentBellos, Nicholaos C., M.D.Phase 2
An Open Label Treatment Protocol to Provide Continued Elvucitabine TreatmentCenter for the Prevention and Treatment of InfectionsPhase 2
An Open Label Treatment Protocol to Provide Continued Elvucitabine TreatmentCentral Texas Primary Care Research NetworkPhase 2

See all Elvucitabine clinical trials

Clinical Trial Summary for Elvucitabine

Top disease conditions for Elvucitabine
Top clinical trial sponsors for Elvucitabine

See all Elvucitabine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.